Article
Dissecting the cell of origin of aberrant SALL4 expression in myelodysplastic syndrome
2022-12-05
Abstract excerpt
Myelodysplastic syndrome (MDS) is a group of heterogeneous diseases characterized by cytologic dysplasia and cytopenias resulting from ineffective hematopoiesis. Oncofetal protein SALL4 is a known oncogene in MDS and its baseline expression level serves as a prognostic biomarker for MDS at the time of diagnosis. In addition, a recent study showed that SALL4 upregulation following hypomethylating agent treatment in...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a3141743-5031-5e47-9950-21126b77de92
- DOI
- 10.1101/2022.12.05.518121
